Correlations between frequencies of FoxP3+ Tregs and CD4+TIM-3+ T cells in TME were stronger in advanced tumor stages, compared to early stages (r = 0.737, p = 0.023 [early]; r = 0.818, p = 0.0006 [advanced]) (Figure 1C). This evidence concerns the gene HAVCR2 and neoplasm.